Skip to main content

Advertisement

Log in

The Therapeutic Effects of Tyrosine Hydroxylase Gene Transfected Hematopoetic Stem Cells in a Rat Model of Parkinson’s Disease

  • Original Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Aims

To investigate the therapeutic effects of tyrosine hydroxylase (TH)-transfected neuronal stem cells derived from bone marrow stem cells (NdSCs-D-BMSCs) on Parkinson’s disease (PD) through different transplantation protocols, including microinjection into the cerebral ventricles (CV) and the striatum (ST).

Methods

After identification by enzyme digestion, the constructed plasmid pEGFP-C2-TH was transfected into 8-day-cultured NdSCs-D-BMSCs by electroporation resulting in the coexpression of green fluorescent protein (GFP) and TH. The TH-transfected cells were injected into either the right ST or CV of PD rats. The changes in locomotor activity of PD rats and the migration of transplanted cells in cerebral tissue were monitored and cerebral DA levels were assayed by high performance liquid chromatography (HPLC).

Results

Five days after plasmid pEGFP-C2-TH transfection into NdSCs-D-BMSCs GFP was expressed in 62.1% of the cells and the rate of co-expression with TH was 83.5%. Ten weeks following transplantation, the symptoms of PD rats in both groups were significantly improved and DA levels were restored to 46.6% and 33% of control. The transferred cells showed excellent survival rates in PD rat brains and distant migration was observed.

Conclusion

Both CV and ST transplantation of TH-transfected NDSCs-D-BMSCs has obvious therapeutic effects on PD rats. This study could provide evidence for future transplantation route selection, possibly leading to stem cell transplantation through lumbar puncture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Berretta N, Freestone PS, Guatteo E, de Castro D, Geracitano R, Bernardi G, Mercuri NB, Lipski J (2005) Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro. Neurotoxicology 26(5):869–881

    Article  CAS  PubMed  Google Scholar 

  • Colter DC, Sekiya I, Prockop DJ (2001) Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells, Proc Nat Acad Sci USA 98(14):7841–7845

    Article  CAS  PubMed  Google Scholar 

  • Debeir T, Ginestet L, Francois C, Laurens S, Martel JC, Chopin P, Marien M, Colpaert F, Raisman-Vozari R (2005) Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus. Exp Neurol 193(2):444–454

    Article  CAS  PubMed  Google Scholar 

  • Jiang X, Xu R, Zhang W (2003) In Vitro experimental study on marking neural stem cells derived from human bone marrow with green fluorescence protein. Chin J Clin Rehab 25(7):3439–3441

    Google Scholar 

  • Kang UJ, Lee WY, Chang JW (2001) Gene therapy for Parkinson’s disease: determining the genes necessary for optimal dopamine replacement in rat models. Hum Cell 14(1):39–48

    CAS  PubMed  Google Scholar 

  • Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605–608

    Article  CAS  PubMed  Google Scholar 

  • Lu L, Zhao C, Liu Y, Sun X, Duan C, Ji M, Zhao H, Xu Q, Yang H (2005) Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson’s disease. Brain Res Prot 15(1):46–51

    Article  CAS  Google Scholar 

  • Paola RD, Uitti RJ (1997) Treatment implications in the early detection of Parkinson’s disease. Med Pro SEA 24(1):8–11

    Google Scholar 

  • Paxinos G, Watson C (1998) The rat brain in stereotatic coordinates, 2nd edn. Academic Press, Burlington, MA

    Google Scholar 

  • Segovia J (2002) Gene therapy for Parkinson’s disease: current status and future potential. Am J Pharmacogenom 2(2):135–146

    Article  CAS  Google Scholar 

  • Shih CC, DiGiusto D, Mamelak A, Lebon T, Forman SJ (2002) Hematopoietic potential of neural stem cells: plasticity versus heterogeneity. Leuk Lymphoma 43(12):2263–2268

    Article  CAS  PubMed  Google Scholar 

  • Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370

    Article  CAS  PubMed  Google Scholar 

  • Yamada H, Dezawa M, Shimazu S, Baba M, Sawada H, Kuroiwa Y, Yamamoto I, Kanno H (2003) Transfer of the von Hippel-Lindau gene to neuronal progenitor cells in treatment for Parkinson’s disease. Ann Neurol 54(3):352–359

    Article  CAS  PubMed  Google Scholar 

  • Yuan H, Sarre S, Ebinger G, Michotte Y (2005) Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson’s disease. J Neurosci Methods 144(1):35–45

    Article  PubMed  Google Scholar 

  • Zhang W, Xu R, Cai Y (2002) The activity change of dopamine D2 receptors in caudal-putamen of Parkinson’s disease model rats. Chi J Neurosurgical Dis Res 1(3):266–268

    CAS  Google Scholar 

  • Zou Z, Zhang S, Jiang X (2006) Experimental study on establishment of PD’s rats model by 6-OHDA directional injection. Chi J Neuromed 5(3):244–247

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shizhong Zhang.

Additional information

Grant: National natural science grant (30270491), Outstanding Science-technology program of Guangdong Province (2000)25.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, S., Zou, Z., Jiang, X. et al. The Therapeutic Effects of Tyrosine Hydroxylase Gene Transfected Hematopoetic Stem Cells in a Rat Model of Parkinson’s Disease. Cell Mol Neurobiol 28, 529–543 (2008). https://doi.org/10.1007/s10571-007-9191-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-007-9191-8

Keywords

Navigation